Therefore, the authors conclude that adenomyosis etiology is strongly associated with KRAS mutations in the endometrium, as well as the status of KRAS mutations is likely to be a critical factor in selecting effective medical treatments. This evidence concerns the gene KRAS and adenomyosis.